Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Clin Nucl Med ; 48(4): 366-369, 2023 Apr 01.
Article in English | MEDLINE | ID: mdl-36735390

ABSTRACT

ABSTRACT: A 37-year-old man with previous heart transplantation for dilated cardiomyopathy underwent screening for malignancy under posttransplantation immunosuppression. 18 F-FDG PET/CT revealed uptake in 2 peritoneal sites of the pericardium that corresponded to the insertion sites of a left ventricular assist device that was used before transplantation. Additional abnormal uptake in the right axillary artery, aortic arch, and left femoral artery corresponded to the insertion sites for arterial inflow during cardiopulmonary bypass. Knowledge that FDG accumulation may occur at the insertion sites of an extracorporeal-circulation device enables unnecessary tests to be avoided.


Subject(s)
Heart Transplantation , Heart-Assist Devices , Male , Humans , Adult , Fluorodeoxyglucose F18 , Positron Emission Tomography Computed Tomography , Positron-Emission Tomography
3.
BMJ Case Rep ; 20172017 Jul 19.
Article in English | MEDLINE | ID: mdl-28724601

ABSTRACT

Liver trauma is a recognised rare complication of cardiopulmonary resuscitation (CPR) and may be difficult to detect. We report a case of intraperitoneal haemorrhage due to liver injury following CPR in a 50-year-old man admitted to the intensive care unit. The haemorrhage was diagnosed with focused assessment with sonography for trauma (FAST). FAST can rapidly and easily diagnose liver injury. FAST is recommended for excluding haemoperitoneum in patients who are haemodynamically unstable after resuscitation.


Subject(s)
Abdominal Injuries/diagnosis , Cardiopulmonary Resuscitation/adverse effects , Hemoperitoneum/diagnosis , Liver/injuries , Ultrasonography/methods , Wounds, Nonpenetrating/diagnosis , Abdominal Injuries/diagnostic imaging , Abdominal Injuries/etiology , Hemoperitoneum/diagnostic imaging , Hemoperitoneum/etiology , Humans , Intensive Care Units , Liver/diagnostic imaging , Male , Middle Aged , Wounds, Nonpenetrating/diagnostic imaging , Wounds, Nonpenetrating/etiology
4.
Low Urin Tract Symptoms ; 7(2): 93-8, 2015 May.
Article in English | MEDLINE | ID: mdl-26663688

ABSTRACT

OBJECTIVES: As a proof-of-mechanism (POM) study of drugs developed to treat stress urinary incontinence (SUI) has not been conducted, this urodynamic study in healthy women was performed to determine an appropriate method to confirm POM, and to evaluate the effect of duloxetine, a serotonin and noradrenaline reuptake inhibitor, on urethral resting pressure and on sphincter contractility in response to coughing and magnetic stimulation. METHODS: The urethral pressure profiles at rest, during coughing and during sacral root magnetic stimulation (SMS), and the motor threshold (MT) for urethral sphincter contraction in response to transcranial magnetic stimulation (TMS) were measured before and 6 h after the administration of 40 mg duloxetine in 10 healthy female subjects. RESULTS: Oral administration of duloxetine significantly increased the mean and maximal urethral closure pressures at rest over the proximal and middle third of the urethra. During coughing, duloxetine marginally significantly increased the mean distal urethral pressure and significantly reduced the mean delay in the distal urethral pressure peak relative to the vesical peak. Although duloxetine did not change amplitudes of pressure spikes in response to SMS, this drug significantly lowered the MT in response to TMS. CONCLUSION: The proposed method for measuring the urethral resistance in healthy women can be used in POM studies of new drugs developed to treat SUI. CLINICAL TRIAL REGISTRATION NUMBER: UMIN000009096.


Subject(s)
Cough , Duloxetine Hydrochloride/pharmacology , Magnetic Field Therapy , Muscle Contraction/drug effects , Serotonin and Noradrenaline Reuptake Inhibitors/pharmacology , Urethra/drug effects , Administration, Oral , Adult , Duloxetine Hydrochloride/administration & dosage , Female , Healthy Volunteers , Humans , Lumbosacral Plexus , Muscle Contraction/physiology , Pressure , Serotonin and Noradrenaline Reuptake Inhibitors/administration & dosage , Urethra/physiology , Urodynamics/drug effects , Urodynamics/physiology
5.
Eur J Pharmacol ; 694(1-3): 104-10, 2012 Nov 05.
Article in English | MEDLINE | ID: mdl-22960063

ABSTRACT

Because hypertension related alterations occur in the properties of α(1)-adrenoceptor in several mammalian tissues and hypertension may impact ejaculatory function, we investigated hypertension related alterations in the functional, biochemical and molecular properties of α(1)-adrenoceptor in the rat seminal vesicle and vas deferens. Spontaneous seminal emission in male spontaneously hypertensive rats (SHRs) and normotensive Wistar-Kyoto (WKY) rats was studied during the 3-day observation period. The characteristics of α(1)-adrenoceptor in the seminal vesicle and epididymal and prostatic portion of vas deferens of the two strains were determined using an isolated muscle bath, radioligand receptor binding and real-time reverse transcription-polymerase chain reaction techniques. SHRs had significantly higher serum testosterone than WKY rats. However, the daily mean number of ejaculatory plugs emitted and their dry weight in SHRs were significantly lower than those in WKY rats. Although there was no significant difference in the properties of α(1)-adrenoceptor in the prostatic portion of vas deferens between SHRs and WKY rats, the maximum contractile responses to phenylephrine, total α(1)-adrenoceptor density and expression of α(1A)-adrenoceptor mRNA were significantly higher in the seminal vesicle and epididymal portion of vas deferens of SHRs vs. WKY rats. Our data demonstrate the presence of hypertension related alterations in serum testosterone and in α(1)-adrenergic responsiveness of the rat seminal vesicle and vas deferens and suggest that ejaculatory function in SHRs does not mirror these hypertension related alterations.


Subject(s)
Blood Pressure , Gene Expression Regulation , Hypertension/metabolism , Muscle Contraction , Receptors, Adrenergic, alpha-1/metabolism , Seminal Vesicles/metabolism , Vas Deferens/metabolism , Animals , Ejaculation , Female , Hypertension/physiopathology , Male , Rats , Rats, Inbred SHR , Seminal Vesicles/physiology , Seminal Vesicles/physiopathology , Vas Deferens/physiology , Vas Deferens/physiopathology
6.
Eur J Pharmacol ; 670(1): 260-5, 2011 Nov 16.
Article in English | MEDLINE | ID: mdl-21910985

ABSTRACT

α(1)-Adrenoceptors regulate blood pressure, regional vascular resistance and tissue blood flow. As aging and hypertension may impact pelvic arterial blood flow resulting in bladder and penile dysfunction, we investigated effects of age and hypertension on α(1)-adrenoceptors in the major source arteries of the rat bladder and penis. Using radioligand receptor binding, real-time reverse transcription-polymerase chain reaction (RT-PCR) and fluorescent microsphere infusion techniques, we compared 3 and 22-month-old male Fischer rats, and male normotensive Wistar-Kyoto (WKY) rats and spontaneously hypertensive rats (SHRs). Twenty-two-month-old rats and SHRs had significantly higher total α(1)-adrenoceptor density in the internal iliac artery and lower blood flow to the bladder and penis than 3-month-old and WKY rats, respectively. RT-PCR data showed an age and hypertension related increase in the expression of α(1B)-adrenoceptor mRNA in the internal iliac, vesical and internal pudendal arteries and a switch from α(1A) predominance in 3-month-old and WKY rats to α(1B)>α(1A) in 22-month-old rats and SHRs. Our data indicate the presence of age and hypertension related alterations in vascular α(1)-adrenoceptor subtype distribution and in blood flow to the rat bladder and penis. These findings suggest that pharmacological blockade of the vascular α(1B)-adrenoceptor, which could increase pelvic blood flow, may contribute to the improvement of bladder and penile dysfunctions in animal models for aging and hypertension.


Subject(s)
Aging/metabolism , Arteries/metabolism , Hypertension/metabolism , Penis/blood supply , Receptors, Adrenergic, alpha-1/metabolism , Urinary Bladder/blood supply , Aging/physiology , Animals , Arteries/physiology , Arteries/physiopathology , Blood Circulation , Hypertension/physiopathology , Male , Rats , Receptors, Adrenergic, alpha-1/genetics , Reverse Transcriptase Polymerase Chain Reaction
7.
Low Urin Tract Symptoms ; 2(2): 83-7, 2010 Sep.
Article in English | MEDLINE | ID: mdl-26676288

ABSTRACT

OBJECTIVES: It has been reported that nitric oxide (NO) mainly contributes to prostate or urethral smooth muscles relaxation, and that nitrergic innervation and neuronal NO synthase (nNOS) levels are decreased in benign prostatic hyperplasia. The purpose of the present study was to evaluate the feasibility to gene therapy for benign prostatic hyperplasia by transferring nNOS gene into the rat prostate with in vivo electroporation (EP) procedure. METHODS: Male Sprague-Dawley rats were divided into four groups (sham, only EP, only nNOS injection, and nNOS gene injection with EP groups). Fifty micrograms of luciferase gene and nNOS expression vectors in 50 µL of K-PBS (potassium-phosphate buffered saline) were injected into the prostate. Immediately after the injection of these vectors, the vector injection points were electroporated by the two-square parallel electrodes. Two days after gene transfer, luciferase analysis and an immunohistochemical staining for nNOS were performed, and NO2 (-) /NO3 (-) (NOX ) release was measured using high-performance liquid chromatography coupled with the microdialysis procedure. RESULTS: The optimal electric pulse conditions were 50 V, 1 Hz and 10 msec. In vivo EP with these conditions showed the increase in the luciferase gene expression approximately 300-fold of the control group. In the nNOS gene injection with EP group, the marked nNOS immunoreactivity was observed, and NOX release was significantly higher, as compared to other groups. CONCLUSION: The results suggest that EP is a feasible technique for in vivo gene transfer into the rat prostate, and that the transferred nNOS gene functionally expresses and contributes to NO production.

8.
Methods Mol Biol ; 423: 249-57, 2008.
Article in English | MEDLINE | ID: mdl-18370204

ABSTRACT

The possibility of in vivo gene transfer into the rat bladder by electroporation (EP) was evaluated. The bladder was exposed through an abdominal midline incision in 8-week-old male rats. Plasmid DNA of marker genes, green fluorescent protein (GFP) and luciferase, and the neuronal nitric oxide synthase (nNOS) gene were then injected into the subserosal space of the bladder and EP was applied. At 72 h after gene transfer, GFP and luciferase were assayed in the isolated bladder, and immunohistochemical staining was used to detect nNOS. NOx released from isolated bladder strips was also assessed using microdialysis procedure. From the luciferase assay, 45 V, 1 Hz, 50 ms, and 8 pulses were selected as the optimum conditions for EP. Bladder specimens with GFP genes injected by EP showed numerous bright sites of GFP expression in the smooth-muscle layer. In rats with the nNOS gene injected by EP, there was marked nNOS immunoreactivity, and NOx released from bladder strips was significantly greater than that in the control groups. These results suggest that EP is a useful technique for in vivo gene transfer into rat bladder smooth muscles, and that the nNOS gene transferred by this procedure functionally expresses and contributes to NO production.


Subject(s)
DNA, Recombinant/administration & dosage , Electrochemotherapy/methods , Genetic Therapy/methods , Urinary Bladder/metabolism , Animals , DNA, Recombinant/genetics , Electroporation/methods , Gene Expression , Gene Transfer Techniques , Genes, Reporter , Genetic Vectors , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Immunohistochemistry , Luciferases/genetics , Luciferases/metabolism , Male , Mice , Nitric Oxide/metabolism , Nitric Oxide Synthase Type I/genetics , Nitric Oxide Synthase Type I/metabolism , Plasmids/administration & dosage , Plasmids/genetics , Rats , Rats, Sprague-Dawley , Recombinant Proteins/genetics , Recombinant Proteins/metabolism
9.
Int J Urol ; 11(11): 1001-8, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15509205

ABSTRACT

BACKGROUND: Muscarinic M3 (M3) receptor has been recognized as a major muscarinic receptor for smooth muscle contractions of the urinary bladder. Under the hypothesis that overexpression of M3 receptor in the urinary bladder would enhance urinary bladder contractions, we have transferred the M3 receptor gene into rat bladders using electroporation (EP) and evaluated the functional expression of the transferred gene. METHODS: Plasmids expressing luciferase, a green fluorescence protein and M3 receptor were injected into the rat bladder and square-wave electric pulses were immediately applied. Two days after gene transfer, we analyzed gene expression. Immunohistochemical staining was performed and the contractile responses from isolated bladder strips, which were induced KCl, carbachol and electrical field stimulation (EFS), were evaluated. RESULTS: The optimal conditions of electroporation were 8 pulses, 45 voltages, 50 milliseconds/pulses and 1 Hz. Under these conditions, luciferase gene expression was enhanced approximately 300-fold, compared to an injection of DNA only. Regarding immunohistochemistry with an anti-M3 receptor, an increase in immunoactivity was observed in the M3 receptor gene transferred rat bladder, compared to the bladder of the control rat. In rats with the transferred M3 receptor gene, carbachol- and EFS-induced maximum contractile responses of bladder smooth muscle strips significantly increased. CONCLUSIONS: These findings suggest that an in vivo EP procedure is an useful method for gene transfer into the bladder and that an overexpression of M3 receptor in the rat bladder enhances bladder contractility. This technique may become a new treatment modality for detrusor underactivity.


Subject(s)
Electroporation , Gene Transfer Techniques , Receptor, Muscarinic M3/genetics , Receptor, Muscarinic M3/metabolism , Urinary Bladder/metabolism , Animals , Carbachol/pharmacology , Cholinergic Agonists/pharmacology , Electric Stimulation , Feasibility Studies , Gene Expression , Immunohistochemistry , In Vitro Techniques , Luciferases/metabolism , Male , Muscle Contraction/drug effects , Muscle Contraction/physiology , Muscle, Smooth/drug effects , Muscle, Smooth/metabolism , Rats , Rats, Sprague-Dawley , Urinary Bladder/physiopathology
10.
Urol Int ; 73(1): 74-80, 2004.
Article in English | MEDLINE | ID: mdl-15263797

ABSTRACT

INTRODUCTION: To investigate the mechanism of voiding dysfunction in non-insulin-dependent diabetes mellitus, we attempted to measure the acetylcholine (ACh) release using an in vivo microdialysis technique and measuring the detrusor pressure after electrical field stimulation (EFS) of the pelvic nerve. MATERIALS AND METHODS: Eight- and 32-week-old female Goto-Kakizaki (GK) rats (non-insulin-dependent diabetes mellitus model) and age-matched female Wistar rats (controls) were used in this study. The pelvic nerve was exposed on a bipolar platinum electrode to EFS, and a cannula was inserted into the bladder to measure the detrusor pressure. The microdialysis probe was inserted into the bladder wall and was connected to a microinfusion syringe pump. Dialysate was constantly perfused, collected in a microtube, and then injected into the ACh assay system. Histological examinations were performed by staining with hematoxylin and eosin and S-100 immunohistochemical staining in bladder preparations of both GK and control rats. RESULTS: In 8-week-old rats, both detrusor pressures and amounts of ACh release of GK rats were not significantly different from those of control rats. In 32-week-old rats, both detrusor pressures and ACh releases were only significantly increased at 5 and 10 Hz of EFS. In the histological study, the number of nerve fibers or bundles of 32-week-old GK rats was significantly decreased as compared with control rats. CONCLUSION: The present data suggest that the decrease in EFS-induced ACh release in GK rats, which may be caused by the decreased number of nerve fibers, may contribute to the decrease in bladder contractions.


Subject(s)
Acetylcholine/metabolism , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Type 2/metabolism , Muscle, Smooth/metabolism , Urinary Bladder/metabolism , Animals , Diabetes Mellitus, Experimental/physiopathology , Diabetes Mellitus, Type 2/physiopathology , Electric Stimulation , Female , Muscle, Smooth/physiopathology , Pressure , Rats , Rats, Wistar , Urinary Bladder/pathology , Urinary Bladder/physiopathology
11.
Urology ; 63(3 Suppl 1): 17-23, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15013648

ABSTRACT

Numerous studies have detailed age-related changes in the structure and function of the bladder that may contribute to the high prevalence of overactive bladder (OAB) in the elderly population, but the relation of these changes to OAB symptoms remains unclear. Physiologic and neurochemical studies have been conducted in human detrusor strips obtained from people of different ages, focusing on potential changes in cholinergic and purinergic neurotransmission, as well as the release and actions of acetylcholine (ACh) from nonneuronal bladder cells. Results from physiologic and microdialysis experiments indicate that purinergic transmission increases with age, whereas cholinergic transmission decreases. These effects are most likely because of decreased release of ACh and increased release of adenosine triphosphate (ATP) from postganglionic parasympathetic axons innervating the bladder. Immunohistochemical experiments showed that choline acetyltransferase in the human detrusor is contained not only in parasympathetic axons, but also in cells of the urothelium. The release of nonneuronal ACh increases with age and detrusor stretch. The age-related increase in purinergic transmission in the detrusor and other data indicating that responses to ATP are increased in detrusor overactivity suggest that purinergic receptor antagonists may provide a useful complement to muscarinic receptor antagonists in the treatment of older patients with OAB. Nonneuronal ACh release may play a key role in the storage phase of the micturition reflex, and this may explain, at least in part, the effectiveness of antimuscarinic agents for the treatment of OAB.


Subject(s)
Acetylcholine/metabolism , Adenosine Triphosphate/metabolism , Aging/physiology , Urinary Bladder/physiology , Urinary Incontinence/physiopathology , Urodynamics/physiology , Aged , Animals , Humans , Mechanoreceptors , Muscle Contraction/physiology , Muscle, Smooth/physiology , Signal Transduction , Urinary Bladder/metabolism
12.
Urol Int ; 71(3): 290-8, 2003.
Article in English | MEDLINE | ID: mdl-14512651

ABSTRACT

KRP-197, 4-(2-methylimidazol-l-yl)-2,2-diphenylbutyramide, is a newly synthesized antimuscarinic drug, developed for the treatment for overactive bladder. For evaluation of pharmacological characteristics of KRP-197, we investigated whether it influenced both prejunctional and postjunctional muscarinic receptors on the isolated human detrusor smooth muscles as compared with the effects of atropine, oxybutynin, and propiverine. Using the muscle bath technique, we investigated the effects of various antimuscarinic drugs on the contractions induced by carbachol, KCl, CaCl(2), and electrical field stimulation. Furthermore, using high-performance liquid chromatography with a microdialysis technique, we measured the acetylcholine release from the muscle strips during electrical field stimulation. The effects of various antimuscarinic drugs on acetylcholine releases were also evaluated. Pretreatment with various antimuscarinic drugs caused parallel shifts to the right in carbachol-induced concentration-response curves. The rank order of pA(2) values was KRP-197 > or = atropine > oxybutynin > propiverine. Atropine and KRP-197 did not cause significant inhibition of KCl- and CaCl(2)-induced contractions. All drugs caused concentration-dependent inhibitions in electrical field stimulation-induced contractions. Pretreatment with atropine and propiverine did not cause significant changes in electrical field stimulation-induced acetylcholine release. However, KRP-197, and oxybutynin caused significant decreases in acetylcholine release. The present study demonstrates that KRP-197 has an inhibitory effect on postjunctional muscarinic receptors as well as on prejunctional muscarinic receptors to modulate acetylcholine release in human detrusor smooth muscles. The findings suggest the usefulness of KRP-197 as a therapeutic drug for an overactive bladder with symptoms of frequency, urgency, and urge incontinence.


Subject(s)
Imidazoles/pharmacology , Urinary Bladder/drug effects , Aged , Dose-Response Relationship, Drug , Female , Humans , In Vitro Techniques , Male , Muscarinic Antagonists/pharmacology
13.
J Vet Med Sci ; 65(4): 535-9, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12736440

ABSTRACT

To determine the effects of ozone on the phagocytosis of bovine polymorphonuclear leukocytes (PMNs), ozone gas was administered in vitro on the blood and milk of healthy lactating cows, cows with acute mastitis, and cows with milk fever. In the blood of healthy dairy cattle, although there was no significant effect of ozone gas on the viability of the leukocytes, phagocytosis of PMNs significantly decreased. In contrast, ozone gas administration in vitro significantly increased phagocytosis of PMNs from the blood of cows with acute mastitis and milk fever, and from mastitic milk. These findings showed that ozone administration in vitro has positive and negative effects on bovine PMN phagocytosis, depending on the health status of the animal.


Subject(s)
Milk/cytology , Neutrophils/drug effects , Oxidants, Photochemical/pharmacology , Ozone/pharmacology , Phagocytosis/drug effects , Animals , Anti-Bacterial Agents/therapeutic use , Cattle , Cattle Diseases/blood , Cattle Diseases/immunology , Cells, Cultured , Female , Kanamycin/therapeutic use , Mastitis, Bovine/blood , Mastitis, Bovine/drug therapy , Mastitis, Bovine/immunology , Neutrophils/immunology , Parturient Paresis/blood , Parturient Paresis/immunology , Penicillins/therapeutic use , Pregnancy , Streptomycin/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...